The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Official Title: An Open-Label, Single Institution, Phase II Study Using Radioactive Yttrium90 Microsphere (SIR-Sphere®) in Uveal Melanoma Patients With Hepatic Metastasis
Study ID: NCT01473004
Brief Summary: The purpose of this study is to determine whether radiation provided locally to the liver tumor vasculature environment will demonstrate a response of tumor decline. This radiation may cause the tumor cells to die.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Name: Takami Sato, MD
Affiliation: Thomas Jefferson University
Role: PRINCIPAL_INVESTIGATOR
Name: Carin Gonsalves, MD
Affiliation: Thomas Jefferson University
Role: PRINCIPAL_INVESTIGATOR